Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,756.00    54.00 (1.15%)
Bid:
4,764.00
Ask:
4,768.00
Spread: 4.00 (0.084%)
Market Cap: £2.22b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Director/PDMR Shareholding

11 Mar 2008 16:28

Morgan Sindall PLC11 March 2008 Morgan Sindall plc ('the Company') Notification of Transactions by Directors and persons discharging managerialresponsibilities Deferred Share Bonus Awards The Company announces the number set out below of nil cost options over ordinaryshares of 5p each in the capital of the Company ('shares') that were exercisedby the executive directors of the Company on 10 March 2008 pursuant to the termsof the Deferred Share Bonus Awards approved by the Company on 24 March 2004.These options represented 25% of the annual bonus earned by the directors inrespect of the year ended 31 December 2004. No long term incentives were made tothe executive directors in respect of that financial year. In addition, Paul Whitmore has disposed of a proportion of the options equal tothe tax and National Insurance Contribution payable in respect of them. These nil cost share options were satisfied from market purchased shares held inthe Morgan Sindall Employee Benefit Trust. Name of Director/PDMR Number of options exercised Number of shares disposed on 10 March 2008 John Morgan 8,046 NilPaul Smith 10,241 NilDavid Mulligan 4,114 NilPaul Whitmore 6,876 2,820 The middle market price of a share at close of business on 10 March 2008 was£9.87. 1995 Share Option Scheme ('1995 scheme') On 10 March 2008, Paul Smith exercised 100,000 share options granted on 10 March2003 under the 1995 scheme with an exercise price of £2.07 per share. Theseoptions were granted to Paul Smith as part of his initial employment package in2003 and in lieu of participation in the Company's Long Term Incentive Plan inrespect of that year. These share options were satisfied by the issue of new shares. Following these transactions, the directors have notified their interests (allof which are beneficial) in the share capital of the Company in accordance withDisclosure Rule 3.1.4R (1) (a) and section 793 of the Companies Act 2006 asfollows: Name of Director/PDMR Beneficial interest in % issued share capital of in shares the Company John Morgan 4,456,658 10.39%Paul Smith 131,913 0.31%David Mulligan 7,364 0.02%Paul Whitmore 16,761 0.04% Enquiries: Mary Nettleship Tel: 020 7307 9218Company Secretary 11 March 2008 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Jun 20261:05 pmRNSAdmission to Trading
12th Jun 202610:25 amRNSDirector/PDMR Shareholding
4th Jun 202611:43 amRNSDirector/PDMR Shareholding
3rd Jun 202611:56 amRNSDirector/PDMR Shareholding
1st Jun 20269:27 amRNSTotal Voting Rights
27th May 20261:29 pmRNSAdmission to Trading
20th May 202611:35 amRNSIssue of Equity
7th May 202612:38 pmRNSResult of AGM
1st May 20261:33 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSTotal Voting Rights
20th Apr 20263:44 pmRNSHolding(s) in Company
16th Apr 20264:09 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSTrading and Outlook for 2026
14th Apr 20262:18 pmRNSAdmission to Trading
1st Apr 20269:53 amRNSTotal Voting Rights
26th Mar 20261:27 pmRNSHolding(s) in Company
24th Mar 202612:56 pmRNSAnnual Financial Report
20th Mar 202612:42 pmRNSIssue of Equity
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
9th Mar 20263:30 pmRNSDirector/PDMR Shareholding
4th Mar 20262:38 pmRNSDirector/PDMR Shareholding
4th Mar 20262:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20263:33 pmRNSIssue of Equity / Admission to Trading
2nd Mar 20269:22 amRNSTotal Voting Rights
26th Feb 20269:53 amRNSDirector Declaration
25th Feb 20267:00 amRNSResults for the Full Year ended 31 December 2025
12th Feb 20267:00 amRNSTrading and Outlook for 2026
2nd Feb 20269:13 amRNSTotal Voting Rights
19th Jan 20267:00 amRNSNotice of Full Year Results
2nd Jan 202611:09 amRNSTotal Voting Rights
16th Dec 202510:16 amRNSAdditional Listing
2nd Dec 20259:12 amRNSTotal Voting Rights
25th Nov 20254:14 pmRNSHolding(s) in Company
12th Nov 20254:07 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:58 amRNSTotal Voting Rights
20th Oct 202511:24 amRNSBlock listing Interim Review
20th Oct 20259:32 amRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSTrading Update and Outlook for 2025
1st Oct 20259:05 amRNSTotal Voting Rights
1st Sep 20258:59 amRNSTotal Voting Rights
4th Aug 20253:09 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults For the Half Year (HY) Ended 30 June 2025
18th Jul 20258:40 amRNSHolding(s) in Company
1st Jul 20259:34 amRNSTotal Voting Rights
25th Jun 20258:47 amRNSAdditional Listing
24th Jun 20257:00 amRNSNotice of Half Year Results
17th Jun 20257:00 amRNSTrading Update and Outlook for 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.